Literature DB >> 16966511

Accelerated weight loss may precede diagnosis in Alzheimer disease.

David K Johnson1, Consuelo H Wilkins, John C Morris.   

Abstract

OBJECTIVES: To determine the association of weight loss and the onset of dementia of the Alzheimer type (DAT) and to characterize the rate of weight change over time in older adults (aged 65-95 years) who develop DAT vs those who remain without dementia.
DESIGN: Rates of weight change were investigated in older adult research participants (N = 449) who were enrolled as control subjects without dementia and followed up longitudinally (6 years on average) at the Alzheimer's Disease Research Center, Washington University School of Medicine. Some individuals (n = 125) eventually developed DAT; the others (n = 324) remained without dementia. Body weight was measured at each annual assessment. Piecewise linear regression and random effects models were used to test longitudinal rates of weight change between the groups.
RESULTS: Participants without dementia lost about 0.6 lb per year. For those individuals who developed DAT, about 1 year before the detection of DAT, the rate of weight loss doubled (1.2 lb per year). As a group, participants who eventually developed DAT weighed less (about 8 pounds) at study enrollment (ie, when they did not have dementia) than participants who remained without dementia.
CONCLUSIONS: Aging with and without DAT is associated with weight loss; however, weight loss may accelerate before the diagnosis of DAT. Specific factors contributing to weight loss are unknown, but these data suggest they operate before the development of DAT. Hence, weight loss may be a preclinical indicator of Alzheimer disease.

Entities:  

Mesh:

Year:  2006        PMID: 16966511     DOI: 10.1001/archneur.63.9.1312

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  120 in total

1.  Weight loss and incident dementia in elderly Yoruba Nigerians: a 10-year follow-up study.

Authors:  Adesola Ogunniyi; Su Gao; Frederick W Unverzagt; Olusegun Baiyewu; Oyewusi Gureje; James Tat Nguyen; Valerie Smith-Gamble; Jill R Murrell; Ann M Hake; Kathleen S Hall; Hugh C Hendrie
Journal:  Int Psychogeriatr       Date:  2010-08-25       Impact factor: 3.878

Review 2.  The Alzheimer's disease mitochondrial cascade hypothesis.

Authors:  Russell H Swerdlow; Jeffrey M Burns; Shaharyar M Khan
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

3.  Role of lean body mass in estimating glomerular filtration rate in Alzheimer disease.

Authors:  James B Wetmore; Robyn A Honea; Eric D Vidoni; Ammar Almehmi; Jeffrey M Burns
Journal:  Nephrol Dial Transplant       Date:  2010-11-23       Impact factor: 5.992

4.  C-reactive protein and memory function suggest antagonistic pleiotropy in very old nondemented subjects.

Authors:  Jeremy M Silverman; Michal Schnaider Beeri; James Schmeidler; Clive Rosendorff; Gary Angelo; Rizalina S Mavris; Hillel T Grossman; Gregory A Elder; Jose Carrion-Baralt; Rebecca West
Journal:  Age Ageing       Date:  2009-01-15       Impact factor: 10.668

5.  Body mass index, weight change, and clinical progression in mild cognitive impairment and Alzheimer disease.

Authors:  Lilah M Besser; Dawn P Gill; Sarah E Monsell; Willa Brenowitz; Dana H Meranus; Walter Kukull; Deborah R Gustafson
Journal:  Alzheimer Dis Assoc Disord       Date:  2014 Jan-Mar       Impact factor: 2.703

Review 6.  Nutrition and neurodegeneration: epidemiological evidence and challenges for future research.

Authors:  Sophie Gillette-Guyonnet; Marion Secher; Bruno Vellas
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

7.  Metabolic syndrome and cognitive decline in early Alzheimer's disease and healthy older adults.

Authors:  Amber S Watts; Natalia Loskutova; Jeffrey M Burns; David K Johnson
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

8.  Amyloid-beta burden predicts prospective decline in body mass index in clinically normal adults.

Authors:  Jennifer S Rabin; Zahra Shirzadi; Walter Swardfager; Bradley J MacIntosh; Aaron Schultz; Hyun-Sik Yang; Rachel F Buckley; Jennifer R Gatchel; Dylan Kirn; Jeremy J Pruzin; Trey Hedden; Nir Lipsman; Dorene M Rentz; Sandra E Black; Keith A Johnson; Reisa A Sperling; Jasmeer P Chhatwal
Journal:  Neurobiol Aging       Date:  2020-03-07       Impact factor: 4.673

9.  Prevention of progression to dementia in the elderly: rationale and proposal for a health-promoting memory consultation (an IANA Task Force).

Authors:  S Gillette Guyonnet; G Abellan Van Kan; S Andrieu; J P Aquino; C Arbus; J P Becq; C Berr; S Bismuth; B Chamontin; T Dantoine; J F Dartigues; B Dubois; B Fraysse; T Hergueta; H Hanaire; C Jeandel; S Lagleyre; F Lala; F Nourhashemi; P J Ousset; F Portet; P Ritz; P Robert; Y Rolland; C Sanz; M Soto; J Touchon; B Vellas
Journal:  J Nutr Health Aging       Date:  2008-10       Impact factor: 4.075

10.  Association Between Leptin, Cognition, and Structural Brain Measures Among "Early" Middle-Aged Adults: Results from the Framingham Heart Study Third Generation Cohort.

Authors:  Victoria Sanborn; Sarah R Preis; Alvin Ang; Sherral Devine; Jesse Mez; Charles DeCarli; Rhoda Au; Michael L Alosco; John Gunstad
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.